Previous Article | Next Article ![]()
Journal of Virology, July 1999, p. 5903-5911, Vol. 73, No. 7
Influenza Branch1 and
Infectious Disease Pathology Activity,2
Division of Viral and Rickettsial Diseases, National Center for
Infectious Diseases, Centers for Disease Control and Prevention,
Atlanta, Georgia 30333
Received 5 January 1999/Accepted 24 March 1999
During 1997 in Hong Kong, 18 human cases of respiratory illness,
including 6 fatalities, were caused by highly pathogenic avian
influenza A (H5N1) viruses. Since H5 viruses had previously been
isolated only from avian species, the outbreak raised questions about
the ability of these viruses to cause severe disease and death in
humans. To better understand the pathogenesis and immunity to these
viruses, we have used the BALB/c mouse model. Four H5N1 viruses
replicated equally well in the lungs of mice without prior adaptation
but differed in lethality for mice. H5N1 viruses that were highly
lethal for mice were detected in multiple organs, including the brain.
This is the first demonstration of an influenza A virus that replicates
systemically in a mammalian species and is neurotropic without prior
adaptation. The mouse model was also used to evaluate a strategy of
vaccination against the highly pathogenic avian H5N1 viruses, using an
inactivated vaccine prepared from nonpathogenic
A/Duck/Singapore-Q/F119-3/97 (H5N3) virus that was antigenically
related to the human H5N1 viruses. Mice administered vaccine
intramuscularly, with or without alum, were completely protected from
lethal challenge with H5N1 virus. Protection from infection was also
observed in 70% of animals administered vaccine alone and 100% of
mice administered vaccine with alum. The protective effect of
vaccination correlated with the level of virus-specific serum antibody.
These results suggests a strategy of vaccine preparedness for rapid
intervention in future influenza pandemics that uses antigenically
related nonpathogenic viruses as vaccine candidates.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Mouse Model for the Evaluation of Pathogenesis
and Immunity to Influenza A (H5N1) Viruses Isolated from
Humans
*
Corresponding author. Mailing address: Influenza
Branch, Mailstop G-16, DVRD, NCID, Centers for Disease Control and
Prevention, 1600 Clifton Road, N.E., Atlanta, GA 30333. Phone: (404)
639-3591. Fax: (404) 639-2334. E-mail: jmk9{at}cdc.gov.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|